K Number
K191539
Device Name
1.5T Endorectal Coil, 3.0T Endorectal Coil, ER Coil Support
Date Cleared
2020-01-31

(235 days)

Product Code
Regulation Number
892.1000
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Endorectal Coil is indicated for use as diagnostic device extension for GE 1.5 T MR Systems and GE 3.0 T MR Systems to produce transverse, sagittal, coronal and oblique images, spectroscopic images and/or spectra, displaying the internal structure of the prostate. These images when interpreted by a trained physician, yield information that may assist in diagnosis.
Device Description
The Endorectal Coil (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946, 3.0T Endorectal Coil O-HLE-030-01900 and ER Coil Support ZUB-01955) is designed for use with a magnetic resonance (MR) system. The coil is designed to work in unison with the Body Coil (BC) of the MR system, which will excite the hydrogen (1H) nuclei with radio frequency (RF) magnetic fields, so that the coil may receive the resultant RF signal from the excited nuclei. The coil is designed as a reusable receive-only coil for high resolution MR examination of the prostate. The coil housing is minimum sized and drop-shaped for better patient comfort. It features a flat top to minimize the distance of the inside receive coil electronics to the prostate. The coil is receive-only (Rx) and consists of a single loop coil element with an integrated low noise preamplifier and a connector to the GE 1.5 T MR-System or GE 3.0 T MR-System. The coil is fixed tuned and matched to the typical loading condition of a prostate examination at the Larmor frequency of 1H at 1.5 T (63.9 MHz) or 3.0 T (127.7 MHz), respectively. Decoupling circuits are integrated in the single loop element providing a decoupling from the Body Coil of the MR System during transmission of the RF excitation pulse. It is recommended to employ an Endorectal Coil Model in combination with the additional available ER Coil Support. The ER Coil Support is designed for use with any Endorectal Coil Model (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946 and 3.0T Endorectal Coil O-HLE-030-01900). It supports stabilizing the Endorectal Coil in any position required by each individual endorectal MR examination. The ER Coil Support features a collet for acceptance of the Endorectal Coil. The Endorectal Coil is fixated inside the collet by tightening of a knurled screw. It offers five degrees of freedom to align the position of the collet with the required spatial position of the Endorectal Coil housing. Two additional knurled screws allow the lock the ER Coil Support in the desired alignment.
More Information

Not Found

No
The device description focuses on the physical components and function of an MR coil and support system, with no mention of software, algorithms, or data processing that would indicate AI/ML. The performance studies evaluate physical imaging parameters like SNR and uniformity, not algorithmic performance.

No
The device is described as a "diagnostic device extension" used to produce images and spectra to "assist in diagnosis," not to treat a condition.

Yes

The "Intended Use / Indications for Use" section explicitly states, "The Endorectal Coil is indicated for use as diagnostic device extension for GE 1.5 T MR Systems and GE 3.0 T MR Systems..." and further notes that the resulting images "yield information that may assist in diagnosis."

No

The device description clearly details physical hardware components (coil housing, coil element, preamplifier, connector, ER Coil Support) designed to interact with an MR system to receive signals. It is not solely software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases or other conditions.
  • Device Function: The Endorectal Coil is a component of an MR imaging system. It works by receiving radio frequency signals from the body to create images of the prostate. This is an in vivo (within the living body) diagnostic process, not an in vitro process.
  • Intended Use: The intended use clearly states it's for producing images and spectra of the prostate, which are then interpreted by a physician to assist in diagnosis. This aligns with imaging diagnostics, not laboratory-based in vitro diagnostics.

Therefore, the Endorectal Coil is a medical device used for in vivo diagnostic imaging, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The Endorectal Coil is indicated for use as diagnostic device extension for GE 1.5 T MR Systems and GE 3.0 T MR Systems to produce transverse, sagittal, coronal and oblique images, spectroscopic images and/or spectra, displaying the internal structure of the prostate.

These images when interpreted by a trained physician, yield information that may assist in diagnosis.

Product codes

MOS

Device Description

The Endorectal Coil (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946, 3.0T Endorectal Coil O-HLE-030-01900 and ER Coil Support ZUB-01955) is designed for use with a magnetic resonance (MR) system. The coil is designed to work in unison with the Body Coil (BC) of the MR system, which will excite the hydrogen (1H) nuclei with radio frequency (RF) magnetic fields, so that the coil may receive the resultant RF signal from the excited nuclei. The coil is designed as a reusable receive-only coil for high resolution MR examination of the prostate.

The coil housing is minimum sized and drop-shaped for better patient comfort. It features a flat top to minimize the distance of the inside receive coil electronics to the prostate. The coil is receive-only (Rx) and consists of a single loop coil element with an integrated low noise preamplifier and a connector to the GE 1.5 T MR-System or GE 3.0 T MR-System. The coil is fixed tuned and matched to the typical loading condition of a prostate examination at the Larmor frequency of 1H at 1.5 T (63.9 MHz) or 3.0 T (127.7 MHz), respectively. Decoupling circuits are integrated in the single loop element providing a decoupling from the Body Coil of the MR System during transmission of the RF excitation pulse.

It is recommended to employ an Endorectal Coil Model in combination with the additional available ER Coil Support. The ER Coil Support is designed for use with any Endorectal Coil Model (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946 and 3.0T Endorectal Coil O-HLE-030-01900). It supports stabilizing the Endorectal Coil in any position required by each individual endorectal MR examination. The ER Coil Support features a collet for acceptance of the Endorectal Coil. The Endorectal Coil is fixated inside the collet by tightening of a knurled screw. It offers five degrees of freedom to align the position of the collet with the required spatial position of the Endorectal Coil housing. Two additional knurled screws allow the lock the ER Coil Support in the desired alignment.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Magnetic Resonance (MR)

Anatomical Site

Prostate

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Trained physician

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Nonclinical tests were performed on a phantom to evaluate the SUBJECT DEVICE concerning applicable imaging parameters Signal to Noise Ratio (SNR) and Image Uniformity. Tests were conducted following NEMA Standards. Test results show an enhanced SNR performance of the SUBJECT DEVICE, while determined Image Uniformity compares well to the results from the PREDICATE DEVICE.

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical Tests:
Nonclinical tests were performed on a phantom to evaluate the SUBJECT DEVICE concerning applicable imaging parameters Signal to Noise Ratio (SNR) and Image Uniformity. Tests were conducted following NEMA Standards. Test results show an enhanced SNR performance of the SUBJECT DEVICE, while determined Image Uniformity compares well to the results from the PREDICATE DEVICE.

Clinical Tests:
Clinical tests were performed in order to check image quality in vivo. Typical sequences for diagnosis were applied (T2 weighted, Propeller, DWI) with standard scan parameters and image orientations (axial and sagittal). Clinical tests show that the SUBJECT DEVICE provides adequate image quality (SNR, penetration depth, contrast, resolution and robustness against artifacts) as well as scan time and patient comfort are good.
Sample clinical images in DICOM format are provided as part of the discussion of the clinical tests submitted.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K060401, K053042

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1000 Magnetic resonance diagnostic device.

(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health & Human Services logo, which features a stylized caduceus. To the right of that is the FDA logo, which is the acronym FDA in a blue box, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

January 31, 2020

RAPID Biomedical GmbH % Mr. Christian Zimmermann Ouality Management & Official Correspondent Kettelerstrasse 3-11 97222 Rimpar, Bavaria GERMANY

Re: K191539

Trade/Device Name: 1.5T Endorectal Coil. O-HLE-015-01899 and O-HLE-015-01946. 3.0T Endorectal Coil, O-HLE-030-01900; ER Coil Support, ZUB-01955 Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: Class II Product Code: MOS Dated: September 17, 2019 Received: December 23, 2019

Dear Mr. Zimmermann:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

1

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known)

K191539

Device Name

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows a logo for Rapid Biomedical. The word "RAPID" is in large, bold, black letters at the top. Below that, the word "Biomedical" is in smaller, bold, black letters. At the bottom, in a smaller font, it says "MR Coils - Made to Measure".

510(k)#: K [For a new submission, leave the 510(k) number blank.]

1.5T Endorectal Coil - O-HLE-015-01899 and O-HLE-015-01946 3.0T Endorectal Coil - O-HLE-030-01900

510(k) Summary K191539

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR § 807.92.

General Information

Date of summary preparation: 2019-06-03

1. Manufacturer

RAPID Biomedical GmbH Kettelerstrasse 3-11 97222 Rimpar, Bavaria, Germany FEI: 3005049692

2. Distributed by

GE Healthcare 3200 Grandview Blvd Waukesha, WI 53188 FEI: 2124823

3. Contact Person

Mr. Christian Zimmermann RAPID Biomedical GmbH Kettelerstr. 3-11 97222 Rimpar, Bavaria, Germany Phone: +49-9365-8826-0 Fax: +49-9365-8826-99 email: christian.zimmermann@rapidbiomed.de

    1. Type of Submission Traditional 510(k) Premarket Notification
  • Classification and Device Name 5. Classification Panel: Radiology Classification Name: Magnetic Resonance Diagnostic Device Accessory Device Class: Class II [21 CFR § 892.1000] Product Code: MOS Product Nomenclature: Coil, Magnetic Resonance, Specialty Common Name: Special Purpose Coil Trade Names: 1.5T Endorectal Coil and 3.0T Endorectal Coil

4

Image /page/4/Picture/0 description: The image shows a logo for Rapid Biomedical. The word "RAPID" is in large, bold, black letters, with the word "Biomedical" underneath in a smaller font. Below that, the text "MR Coils - Made to Measure" is visible in a smaller font size.

510(k)#: K [For a new submission, leave the 510(k) number blank.]

MR Coils - Made to Measure

1.5T Endorectal Coil - O-HLE-015-01899 and O-HLE-015-01946 3.0T Endorectal Coil - O-HLE-030-01900

Safety and Effectiveness Information Supporting Substantial Equivalence

Indications for Use

The Endorectal Coil is indicated for use as diagnostic device extension for GE 1.5 T MR Systems and GE 3.0 T MR Systems to produce transverse, sagittal, coronal and oblique images, spectroscopic images and/or spectra, displaying the internal structure of the prostate.

These images when interpreted by a trained physician, yield information that may assist in diagnosis.

Device Description

The Endorectal Coil (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946, 3.0T Endorectal Coil O-HLE-030-01900 and ER Coil Support ZUB-01955) is designed for use with a magnetic resonance (MR) system. The coil is designed to work in unison with the Body Coil (BC) of the MR system, which will excite the hydrogen (1H) nuclei with radio frequency (RF) magnetic fields, so that the coil may receive the resultant RF signal from the excited nuclei. The coil is designed as a reusable receive-only coil for high resolution MR examination of the prostate.

The coil housing is minimum sized and drop-shaped for better patient comfort. It features a flat top to minimize the distance of the inside receive coil electronics to the prostate. The coil is receive-only (Rx) and consists of a single loop coil element with an integrated low noise preamplifier and a connector to the GE 1.5 T MR-System or GE 3.0 T MR-System. The coil is fixed tuned and matched to the typical loading condition of a prostate examination at the Larmor frequency of 1H at 1.5 T (63.9 MHz) or 3.0 T (127.7 MHz), respectively. Decoupling circuits are integrated in the single loop element providing a decoupling from the Body Coil of the MR System during transmission of the RF excitation pulse.

It is recommended to employ an Endorectal Coil Model in combination with the additional available ER Coil Support. The ER Coil Support is designed for use with any Endorectal Coil Model (1.5T Endorectal Coil O-HLE-015-01899, 1.5T Endorectal Coil O-HLE-015-01946 and 3.0T Endorectal Coil O-HLE-030-01900). It supports stabilizing the Endorectal Coil in any position required by each individual endorectal MR examination. The ER Coil Support features a collet for acceptance of the Endorectal Coil. The Endorectal Coil is fixated inside the collet by tightening of a knurled screw. It offers five degrees of freedom to align the position of the collet with the required spatial position of the Endorectal Coil housing. Two additional knurled screws allow the lock the ER Coil Support in the desired alignment.

5

Image /page/5/Picture/0 description: The image shows a logo for "Rapid Biomedical". The word "RAPID" is in large, bold, black letters. Below that, the word "Biomedical" is in smaller, bold, black letters with a line underneath. Underneath that, the text "MR Coils - Made to Measure" is in a smaller, black font.

510(k)#: K [For a new submission, leave the 510(k) number blank.]

1.5T Endorectal Coil - O-HLE-015-01899 and O-HLE-015-01946 3.0T Endorectal Coil - O-HLE-030-01900

Equivalency Information

RAPID Biomedical believes that the SUBJECT DEVICE is substantially equivalent to the cleared PREDICATE DEVICE which is described in the following submission.

PREDICATE DEVICEClearance NumberDate
MEDRAD 3.0T eCoil Imaging SystemK06040103/15/2006
MEDRAD 1.5T Pelvic Imaging System
Interface DeviceK05304211/17/2005

Summary of Technological Characteristics of the SUBJECT DEVICE as compared with the PREDICATE DEVICE

The proposed labelling is adjusted compared to the PREDICATE DEVICE with respect to differing MR Systems, changes in the currently applicable standards and for better usability.

Overall, the indications for use, the intended use and the coil technology and safety are substantially equivalent.

General Safety and Effectiveness Concerns

The safety and performance parameters for SUBJECT DEVICE according to the FDA Guidance Document "Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices, issued on Nov. 18, 2016" are equivalent or better than for the PREDICATE DEVICE.

Nonclinical Tests

Nonclinical tests were performed on a phantom to evaluate the SUBJECT DEVICE concerning applicable imaging parameters Signal to Noise Ratio (SNR) and Image Uniformity. Tests were conducted following NEMA Standards. Test results show an enhanced SNR performance of the SUBJECT DEVICE, while determined Image Uniformity compares well to the results from the PREDICATE DEVICE.

The SUBJECT DEVICE is conforming to:

  • AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, c1:2009/(r)2012 and . a2:2010/(r)2012 (consolidated text) medical electrical equipment - part 1: general requirements for safety and essential performance (iec 60601-1;2005, mod), (General II (ES/EMC)). FDA Recognition number: #19-4.
  • IEC 60601-2-33 Ed. 3.2 b:2015: Medical electrical equipment Part 2-33: Particular . requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis. FDA Recognition number: #12-295.
  • NEMA Standards Publication MS 6-2008 (R2014) Determination of Signal-to-Noise . Ratio and Image Uniformity for Single-Channel Non-Volume Coils in Diagnostic MR Imaging. FDA Recognition number: #12-195.

6

Image /page/6/Picture/0 description: The image is a logo for Rapid Biomedical. The logo has the word "RAPID" in large, bold, black letters on the top line. The word "Biomedical" is in a smaller font size and is located below the word "RAPID". The phrase "MR Coils - Made to Measure" is located at the bottom of the logo.

510(k)#: K [For a new submission, leave the 510(k) number blank.]

1.5T Endorectal Coil - O-HLE-015-01899 and O-HLE-015-01946 3.0T Endorectal Coil - O-HLE-030-01900

All safety tests were performed on GE MR Systems. The test results are approved by GE for proving the full system compatibility.

Clinical Tests

Clinical tests were performed in order to check image quality in vivo. Typical sequences for diagnosis were applied (T2 weighted, Propeller, DWI) with standard scan parameters and image orientations (axial and sagittal). Clinical tests show that the SUBJECT DEVICE provides adequate image quality (SNR, penetration depth, contrast, resolution and robustness against artifacts) as well as scan time and patient comfort are good.

Sample clinical images in DICOM format are provided as part of the discussion of the clinical tests submitted.

Conclusion as to Substantial Equivalence

Testing was performed to support this claim of substantial equivalence and to show that the modifications do not raise any new questions pertaining to safety and effectiveness.

The modifications did not affect the Indications for Use, the Intended Use and did not alter the Fundamental Scientific Technology.

RAPID Biomedical therefore believes the SUBJECT DEVICEs and the PREDICATE DEVICEs to be substantially equivalent (SE).

Rimpar, 2019-06-04

Signature:

Name:

Christian Zimmermann (Quality Management & Official Correspondent)